Buradasınız

YETERSİZ PARATÎROÎDEKTOMÎ SONUCU GELİŞEN BROWN TÜMÖRLERİN EŞLÎK ETTİĞİ BÎR ÜREMİK KEMİK HASTALIĞI OLGUSU

A CASE WITH UREMIC BONE DISEASE ASSOCIATED WITH BROWN TUMORS AFTER INSUFFICIENT PARATHYROIDECTOMY

Journal Name:

Publication Year:

Abstract (2. Language): 
Almost ten percent of the patients with high-turnover uremic bone disease have brown tumors. We present here a 63-year-old male patient, on regular hemodialysis for twelve years, with subcutaneous tumoral masses appeared after subtotal thyroidectomy performed to excise four parathyroid adenomas two years ago. The patient, lost for follow-up for two years, was admitted to hospital with the complaints of severe itching, fatigue and two solid masses located, on bilateral sterno-clavicular junction two years after surgical procedure. Examinations showed a permanent pacemaker, CaxP product: 82, parathormone level (PTH): 1991 pg/ml and two residual adenomas confirmed with Tc99m MIBI (methoxyisobulil isonitrile) parathroid scintigraphy. Brown tumors were diagnosed by tru-cut biopsies of the lesions and pulmonary uptake was demonstrated in lung scintigraphy. The PTH levels returned to normal, persistant itching and fatigue disappeared after excisions of residual parathyroid adenomas and sternoclavicular lesions.
Abstract (Original Language): 
Yüksek dönüşümlü üremik kemik hastalığı (ÜKH) olan hastaların yaklaşık %10'unda brown tümör görülür. Burada, iki yıl önce paratiroid adenomu çıkartılması için subtotal tiroidektomi yapıldıktan soma subkutan tumoral kitleler ile başvurmuş, oniki yıldır düzenli hemodiyaliz tedavisi gören 63yaşında bir erkek hasta sunmaktayız. İki yıl boyunca takip edilemeyen hasta; şiddetli kaşıntı, halsizlik ve cerrahiden iki yıl sonra her ikisternoklavikuler bileşkede'/okalize olan iki-solid kitle ile hastaneye müracaat etmftir. Yapılan incelemeler ile hastada kalıcı pacemaker varlığı, Ca x P çarpımı: 82, paratharmon (PTH) düzeyi: .1991 pg/ml,. Tc99 m MIB1 (methoxy isobutyl isonitrile) paratiroid sintigrafisinde iki adet rezidüel adenom saptanmıştır. Lezyonlara yapılan tru-cut biopsiler ile brown tümör tanısı konmuş, akciğer sintigrafisinde pulmoner tutulum belirlenmiştir. Residue! paratiroid adenomlarının ve sternoklavikuler lezyonların eksizyonu sonunda PTH düzeyleri normale dönmüş, inatçı kaşıntı ve halsizlik kaybolmuştur.
FULL TEXT (PDF): 
182-185

REFERENCES

References: 

1. Llach F, Bover J. Renal osteodistrophies. In: Brenner BM (ed), The Kidney. W.B. Saunders Company, Philadelphia 2000, pp 2103-2186.
2. Sherrard DJ, Hercz G, Pei Y. The spectrum of bone disease in end-stage renal failure - on evolving disorder. Kidney Int 1993; 43:436-442.
Resim
7
: Tc 99 m MDP (Methylene diphosphonate) Akciğer Sintigrafisi
3. Nassar GM, Ayus JC. Brown tumor in end-stage renal disease. N EnglJ Med 1999; 341 (22): 1625.
4. Fineman I, Johnson İP, Di Patre PL, Sondhu H.
Chronic renal failure causing brown tumors and
myelopathy. J Neurosurg 1999; 90:242-246.
5. Balon BP, Kayalar P. Brown tumor in association with secondary hyperparathyroidism. Am J Nephrol 1998;
18 (5): 460-463.
6. Scholl RJ, Kellett HM, Neumann DP, Luric AG. Cysts
and cystic lesions; clinical and radiologic-histopathologic review. Radiographics 1995; 19 (5): 1107-1124.
7. Okada H, Davies JE, Yamamoto H. Brown tumor of the maxilla in a patient with secondary hyperparathyroidism. J Oral Maxillofac Surg 2000; 58
(2): 233-238.
8. Caixas A, Berna L, Piera J. Utility of 99mTc- ses t amibi
scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin
Endocrinol 1995;43:525-530.
9. Hopkins CR, Reading CC. Thyroid and parathyroid
imaging. Semin US CT MRI 1995; 16:279-295.
10. Gayed IW, Elshazly SM, Vang RS, Barton BJ, Lamki
LM. Technetium-99 M sestamibi uptake in a maxillar
brown tumor. Clin Nucl Med 2001; 26 (1): 65-67.

Thank you for copying data from http://www.arastirmax.com